{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"MMRC Horizon One:  A Phase II Randomized adaptive platform Trial evaluating novel therapies in relapsed or refractory multiple myeloma","item":"https:\/\/www.regionalcancercare.org\/trials\/mmrc-horizon-one-a-phase-ii-randomized-adaptive-platform-trial-evaluating-novel-therapies-in-relapsed-or-refractory-multiple-myeloma\/#breadcrumbitem"}]}